Article
Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1‐ABCG2 signaling
29 Oct 2015
Abstract excerpt
Platinum‐based chemotherapies have long been used as a standard treatment in non‐small cell lung cancer (NSCLC). However, cisplatin resistance is a major problem that restricts the use of cisplatin. Lung cancer stem cells (LCSCs) represent a subpopulation that is responsible for chemo‐resistance. We aim to investigate the biological function of SLC27A2 and its underlying mechanisms in regulating chemo‐resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
